An interesting strategy for the discovery of glaucoma biomarkers would include proteomics and/or metabolomics studies on the sera of families with Mendelian inheritance of glaucoma, including those with myocilin mutations causing 3–4% of POAG. Here, MYOC is linked to glaucoma.